Skip to main content
Premium Trial:

Request an Annual Quote

Indica Labs Forges Digital Pathology Distribution Deals in Asia-Pacific Region

NEW YORK – Indica Labs said Tuesday that it has inked distribution deals with four companies to offer Indica's digital pathology software in new markets in the Asia-Pacific region.

The Albuquerque, New Mexico-based firm said it has signed agreements with MRL Cybertec for the distribution of the company's products in the Philippines, Pathology Ware International for sales in Thailand, Minh Khang Technical Service & Trading for sales in Vietnam, and Histocenter for sales in Malaysia. The agreements apply to Indica Labs' Halo AP digital pathology workflow software, its Halo AI and Halo Link applications for artificial intelligence-based quantitative image analysis and image management, and its artificial intelligence-based research-use-only applications including Halo Prostate AI, Lung PD-L1 AI, Breast IHC AI, and SlideQC BF.

Indica said in a statement that its partners have been successful sellers of digital pathology instruments and software, and it expects the new partnerships will build on Indica's commercial successes and recent sales growth in China and Japan.

"We are delighted to expand our reach in the APAC region by onboarding resellers whose extensive digital pathology experience and existing customer base will facilitate immediate results and high-quality support of our products in the region," Indica Labs CEO Steven Hashagen said in the statement.

Indica's Halo AP platform is CE-IVDR marked for use in Europe, and its Halo AI Prostate software is CE marked for diagnostic use. The company said in May that it had received US Food and Drug Administration 510(k) clearance for its Halo AP Dx platform for in vitro diagnostic use and the firm planned to continue offering its Halo AP platform in the US for research-use-only applications.